CFDE Data Portal | Search ACTG1P22

	Label	Description
	ACTG1P22 Gene (Entity type)	ENSG00000271615 - actin gamma 1 pseudogene 22
	GSE93156 idelalisib B cell 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE48812 sulforaphane 2 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 5 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE115384 CELSR2 knockdown 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE152699 GSE152723 vemurafenib 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE193838 catechin 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE212312 FBXW7 knockout Reh 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE200538 butyrolactone Hep-G2 1 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

ACTG1P22

ENSG00000271615 - actin gamma 1 pseudogene 22

GSE93156 idelalisib B cell 1 v 0 human dn

A Gene Set from LINCS

GSE48812 sulforaphane 2 v 5 human up

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 5 v 8 human dn

A Gene Set from LINCS

GSE115384 CELSR2 knockdown 5 v 1 human dn

A Gene Set from LINCS

GSE152699 GSE152723 vemurafenib 3 v 2 human up

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE193838 catechin 0 v 2 human dn

A Gene Set from LINCS

GSE212312 FBXW7 knockout Reh 2 v 0 human up

A Gene Set from LINCS

GSE200538 butyrolactone Hep-G2 1 v 2 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.